Skip to main content
. 2020 Jan 30;27(5):1372–1384. doi: 10.1245/s10434-019-08192-z

Fig. 4.

Fig. 4

Overall survival analysis according to the number of lesions. The survival benefit of ALPPS over chemotherapy only can be found in patients with a single lesion (group A, p = 0.004) but not in patients with multiple lesions (group B, p = 0.247)